Russell Investments Group, Ltd. Tcr2 Therapeutics Inc. Transaction History

Russell Investments Group, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$16.41 - $24.71 $155,041 - $233,460	-9,448 Closed	0 $0
Q4 2020 Feb 08, 2021	SELL	$19.0 - $32.63 $49,172 - $84,446	-2,588 Reduced 21.5%	9,448 $292,000
Q3 2020 Nov 09, 2020	BUY	$13.1 - $20.69 $123,768 - $195,479	9,448 Added 365.07%	12,036 $243,000
Q2 2020 Aug 05, 2020	BUY	$6.51 - $16.85 $16,847 - $43,607	2,588 New	2,588 $39,000

Ticker TCRR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,606,400
Description
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.